Skip to main content
Longevity Stack
Peptides/Regenerative

GHK-Cu

Grade C

The important distinction almost every vendor blurs: the human evidence for GHK-Cu is topical, not injected. Small placebo-controlled facial trials show meaningful collagen gains from creams. There are no comparable trials of injected GHK-Cu, so the systemic and anti-ageing claims made for the injectable form are extrapolated from studies that used a completely different route of administration.

Category
Regenerative
Evidence grade
C
Route
Topical (where the evidence is) or subcutaneous injection (where it is not)
Half-life
Not well characterised systemically. Applied topically it acts locally; injected, plasma clearance is rapid and copper handling becomes the limiting concern.
Typical dose
Topical 1-2% cream or serum
Frequency
Once or twice daily
Cycle length
12 weeks before judging — collagen turnover is slow
Best timing
Evening, on clean skin; do not layer with vitamin C, which strips the copper
What researchers are investigating

Skin, collagen, wound repair. The important distinction almost every vendor blurs: the human evidence for GHK-Cu is topical, not injected. Small placebo-controlled facial trials show meaningful collagen gains from creams. There are no comparable trials of injected GHK-Cu, so the systemic and anti-ageing claims made for the injectable form are extrapolated from studies that used a completely different route of administration.

Read the list below as hypotheses, not benefits. This compound is graded C: the effects described come from animal studies, cell work or anecdote — reliable human trials are absent.

  • Around 28% average increase in skin collagen over 3 months in a small topical trial
  • Outperformed vitamin C and retinoic acid for collagen stimulation in the same comparison
  • Long real-world safety record as a cosmetic ingredient
  • Improved wound healing in controlled animal and early human work
Typical dose
Topical 1-2% cream or serum
Frequency
Once or twice daily
Route
Topical (where the evidence is) or subcutaneous injection (where it is not)
Evidence
Grade C

Mechanism of Action

A copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with a copper ion — that occurs naturally in plasma and falls with age. It raises TGF-beta receptor expression and amplifies SMAD2/3 signalling, increasing transcription of matrix genes including collagens, fibronectin and proteoglycans.

Typical Protocol

Dose
Topical 1-2% cream or serum
Frequency
Once or twice daily
Duration
12 weeks before judging — collagen turnover is slow
Timing
Evening, on clean skin; do not layer with vitamin C, which strips the copper
Route
Topical (where the evidence is) or subcutaneous injection (where it is not)
Half-life
Not well characterised systemically. Applied topically it acts locally; injected, plasma clearance is rapid and copper handling becomes the limiting concern.

Educational reference only — not medical advice.

Pharmacokinetics & Dosing Rationale

GHK-Cu is administered topical (where the evidence is) or subcutaneous injection (where it is not) with an approximate systemic half-life of Not well characterised systemically. Applied topically it acts locally; injected, plasma clearance is rapid and copper handling becomes the limiting concern.. Steady-state and tissue-level effects can outlast plasma concentration, which is why dosing frequency (Once or twice daily) is designed to match receptor kinetics rather than plasma exposure. A copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with a copper ion — that occurs naturally in plasma and falls with age. It raises TGF-beta receptor expression and amplifies SMAD2/3 signalling, increasing transcription of matrix genes including collagens, fibronectin and proteoglycans.

How to Administer

  1. Route: Topical (where the evidence is) or subcutaneous injection (where it is not). Typical starting dose Topical 1-2% cream or serum, Once or twice daily.
  2. Timing: Evening, on clean skin; do not layer with vitamin C, which strips the copper — keep it the same each dosing day to make effects legible.
  3. Cycle length: 12 weeks before judging — collagen turnover is slow. Reassess with bloods and symptom logs before repeating.
  4. Rotate sites across the abdomen (avoiding a 2 cm radius around the navel), outer thighs and flanks. Never inject through a bruise or mole.

Reconstitution & Injection Technique

  1. Reconstitute lyophilised powder with bacteriostatic water (0.9% benzyl alcohol) — sterile water is acceptable but shortens shelf life to ~72 hours.
  2. Typical dilution: add 2 mL of bacteriostatic water to a 5 mg vial → 2.5 mg/mL; a 10-unit insulin syringe mark = 0.25 mg.
  3. Inject the diluent slowly against the vial wall — never onto the powder — and gently swirl. Do not shake; peptides denature under shear.
  4. Once reconstituted, store upright in the refrigerator (2–8 °C) and use within 30 days.
  5. Draw the dose with an insulin syringe (29–31G, 8 mm), swab the site with alcohol, pinch subcutaneous tissue on the abdomen or thigh, inject at 90°.

Sterile technique is not optional. Use a fresh needle for every injection.

Cycling & Stacking Strategy

  • Standard protocol: Topical 1-2% cream or serum, Once or twice daily, for 12 weeks before judging — collagen turnover is slow.
  • Ramp up: start at the lower end of the dose range for the first 7–10 days to gauge tolerance and side effects before titrating.
  • Break periods let receptor sensitivity and endogenous feedback loops normalise — running back-to-back cycles without a wash-out erodes the effect.
  • Common stack: Topical retinoid on alternate nights, Daily SPF, Dietary collagen or glycine. Introduce one compound at a time so you can attribute effect and side effect.

Who This Is For

Good candidates
  • Adults with a specific, measurable goal aligned to skin, collagen, wound repair.
  • People who already have baseline bloods, a training routine and a sleep protocol in place.
  • Users who can commit to a full cycle, log the protocol, and re-test biomarkers to evaluate response.
  • Anyone working with a clinician willing to supervise off-label or investigational protocols.
Not appropriate for
  • Anyone with active or recent malignancy, or a strong family cancer history where mechanism is angiogenic or growth-promoting.
  • Pregnant or breastfeeding women — human safety data is absent for almost all research peptides.
  • Adolescents and anyone under 21 whose endocrine axis is still developing.
  • People unwilling to run baseline and post-cycle bloods.
  • Specific contraindications for GHK-Cu: Wilson's disease or any disorder of copper metabolism; Known copper allergy; Pregnancy and lactation — no data.

What to Monitor

Injury / pain score (VAS 0–10)Log weekly at rest and after loading — the primary outcome you care about.
Range of motion / functional testRepeat the same test weekly to see objective recovery.
Skin, mole & lymph checkAngiogenic peptides warrant a baseline dermatology check.
Take it with you

Download a printable version of this checklist to log baseline, weekly and post-cycle results.

Reported Benefits

  • Around 28% average increase in skin collagen over 3 months in a small topical trial
  • Outperformed vitamin C and retinoic acid for collagen stimulation in the same comparison
  • Long real-world safety record as a cosmetic ingredient
  • Improved wound healing in controlled animal and early human work

Safety Profile

Side effects
  • Skin irritation or contact dermatitis in a minority of users
  • Copper accumulation is a theoretical concern with injected use over time
  • Temporary blue-green staining of skin or clothing from the copper complex
Contraindications
  • Wilson's disease or any disorder of copper metabolism
  • Known copper allergy
  • Pregnancy and lactation — no data
Known interactions
Open interactions explorer →
Vitamin C (topical)Ascorbic acid reduces the copper and inactivates the complex. Apply at different times of day.
Zinc supplementationZinc and copper compete for absorption; high-dose zinc can deplete copper.
Retinoids (topical)Commonly layered, but combined irritation is the usual reason people abandon both.
Storage & handling
  • Unreconstituted vials: store at 2–8 °C long-term; brief room-temperature excursions during shipping are usually acceptable.
  • Reconstituted vials: refrigerate at 2–8 °C, protect from light, use within 30 days.
  • Freezing: acceptable for unreconstituted powder if long-term storage is required; avoid repeated freeze-thaw cycles.
  • Never use a vial that appears cloudy, discoloured or has visible particulates.

Common Mistakes

  • Chasing a bigger dose instead of consistency — GHK-Cu outcomes track cumulative exposure, not peak concentration.
  • Skipping baseline bloods, so there is no way to know whether the cycle actually moved a biomarker.
  • Stacking three or four novel compounds at once — you lose the ability to attribute any effect or side effect.
  • Ignoring the training, sleep and nutrition fundamentals that are prerequisites for every peptide protocol.
  • Reusing insulin needles or failing to rotate injection sites — a preventable cause of local reactions and lipohypertrophy.

Evidence Grade — C

Grade C — mechanistic hypothesis and animal or in-vitro data only. No controlled human trials. Treat as experimental; risks are not fully known.

Below are the primary references used to grade GHK-Cu. Follow the links for full-text where available and cross-check against the current literature.

Frequently Asked Questions

What is the typical GHK-Cu protocol?+

Topical 1-2% cream or serum, Once or twice daily, for 12 weeks before judging — collagen turnover is slow. Route: Topical (where the evidence is) or subcutaneous injection (where it is not). Timing: Evening, on clean skin; do not layer with vitamin C, which strips the copper. Half-life: Not well characterised systemically. Applied topically it acts locally; injected, plasma clearance is rapid and copper handling becomes the limiting concern..

How does GHK-Cu work?+

A copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with a copper ion — that occurs naturally in plasma and falls with age. It raises TGF-beta receptor expression and amplifies SMAD2/3 signalling, increasing transcription of matrix genes including collagens, fibronectin and proteoglycans.

How long before I see results from GHK-Cu?+

Most users track a full 12 weeks before judging — collagen turnover is slow cycle before judging response. Subjective changes can appear within 1–3 weeks, but objective biomarker shifts typically need the full cycle plus repeat labs.

Is GHK-Cu legal?+

Copper tripeptide-1 is a long-established, legal cosmetic ingredient in topical products. Injectable GHK-Cu is not approved for human use in any major jurisdiction and is sold only as a research chemical.

What are the main side effects of GHK-Cu?+

Skin irritation or contact dermatitis in a minority of users; Copper accumulation is a theoretical concern with injected use over time; Temporary blue-green staining of skin or clothing from the copper complex.

What should I stack with GHK-Cu?+

Commonly combined with: Topical retinoid on alternate nights, Daily SPF, Dietary collagen or glycine. Introduce one compound at a time to preserve attribution.

What biomarkers should I monitor on GHK-Cu?+

Baseline and post-cycle: full blood count, comprehensive metabolic panel, and category-specific markers for regenerative peptides (see the monitoring section on this page).

Can I run GHK-Cu back-to-back?+

Off-cycle periods let receptor sensitivity and endogenous feedback normalise. Continuous dosing without a wash-out typically produces diminishing returns and a poorer safety margin.

References

  1. [1]Epigenetic mechanisms activated by GHK-Cu increase skin collagen density in a clinical trial — Cosmetics (MDPI), 2018
  2. [2]Skin regenerative and anti-cancer actions of copper peptides — Cosmetics (MDPI), 2018

Further reading: Research library → · Protocols →

Comparison vs Alternatives

Open full comparison →All Peptides →
AttributeGHK-CuThis pageBPC-157TB-500
EvidenceGrade CGrade BGrade B
CategoryRegenerativeRegenerativeRegenerative
Best forSkin, collagen, wound repairTissue repair, gut integritySoft tissue regeneration
Typical doseTopical 1-2% cream or serum250–500 mcg2–5 mg
FrequencyOnce or twice daily1–2× daily2× per week loading (4 weeks), then 2–5 mg weekly maintenance
RouteTopical (where the evidence is) or subcutaneous injection (where it is not)Subcutaneous or oral (gut-localized)Subcutaneous or intramuscular injection
Legal statusCopper tripeptide-1 is a long-established, legal cosmetic ingredient in topical products. Injectable GHK-Cu is not approved for human use in any major jurisdiction and is sold only as a research chemical.Not approved by the FDA for human use. Sold as a research chemical in most jurisdictions.WADA-prohibited at all times (S2 class). Research chemical; not approved for human therapeutic use.
ActionCurrent pageView →View →